NGF is an essential survival factor for bronchial epithelial cells during respiratory syncytial virus infection

PLoS ONE

Volumn 4, Issue 7, 2009, Pages

  Othumpangat, Sreekumar ^a   Gibson, Laura F ^a   Samsell, Lennie ^a   Piedimonte, Giovanni ^a  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; LIPOCORTIN 5; MESSENGER RNA; NERVE GROWTH FACTOR; NEUROTROPHIC FACTOR; NEUROTROPHIN RECEPTOR P75; PROTEIN TYROSINE KINASE A; SMALL INTERFERING RNA; PRIMER DNA;

APOPTOSIS; ARTICLE; BRONCHUS MUCOSA; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; FLOW CYTOMETRY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; NOSE MUCOSA; PROTEIN ANALYSIS; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN TARGETING; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR AFFINITY; RECEPTOR DOWN REGULATION; RESPIRATORY EPITHELIUM; RESPIRATORY TRACT INFECTION; TRACHEA MUCOSA; BRONCHUS; CELL CULTURE; CYTOLOGY; EPITHELIUM CELL; FLUORESCENCE MICROSCOPY; GENE SILENCING; GENETICS; NUCLEOTIDE SEQUENCE; PATHOLOGY; PHYSIOLOGY; POLYMERASE CHAIN REACTION; RESPIRATORY SYNCYTIAL VIRUS INFECTION;

RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS;

BASE SEQUENCE; BRONCHI; CELL SURVIVAL; CELLS, CULTURED; DNA PRIMERS; EPITHELIAL CELLS; FLOW CYTOMETRY; GENE KNOCKDOWN TECHNIQUES; HUMANS; MICROSCOPY, FLUORESCENCE; NERVE GROWTH FACTOR; POLYMERASE CHAIN REACTION; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RNA, SMALL INTERFERING;

EID: 68149110377     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0006444     Document Type: Article

References (43)

1. Panitch HB (2001) Bronchiolitis in infants. Curr Opin Pediatr 13: 256-260.
2. Piedimonte G (2003) Contribution of neuroimmune mechanisms to airway inflammation and remodeling during and after respiratory syncytial virus infection. Pediatr Infect Dis J 22: S66-74; discussion S74-65.
3. Psarras S, Papadopoulos NG, Johnston SL (2004) Pathogenesis of respiratory syncytial virus bronchiolitis-related wheezing. Paediatr Respir Rev 5 Suppl A: S179-184.
4. Steiner RW (2004) Treating acute bronchiolitis associated with RSV. Am Fam Physician 69: 325-330.
5. Openshaw PJ, Dean GS, Culley FJ (2003) Links between respiratory syncytial virus bronchiolitis and childhood asthma: clinical and research approaches. Pediatr Infect Dis J 22: S58-64; discussion S64-55.
6. Schauer U, Hoffjan S, Bittscheidt J, Kochling A, Hemmis S, et al. (2002) RSV bronchiolitis and risk of wheeze and allergic sensitisation in the first year of life. Eur Respir J 20: 1277-1283.
7. Falsey AR, Walsh EE, Capellan J, Gravenstein S, Zambon M, et al. (2008) Comparison of the safety and immunogenicity of 2 respiratory syncytial virus (rsv) vaccines-nonadjuvanted vaccine or vaccine adjuvanted with alum-given concomitantly with influenza vaccine to high-risk elderly individuals. J Infect Dis 198: 1317-1326.
8. Sikkel MB, Quint JK, Mallia P, Wedzicha JA, Johnston SL (2008) Respiratory syncytial virus persistence in chronic obstructive pulmonary disease. Pediatr Infect Dis J 27: S63-70.
9. Hu C, Wedde-Beer K, Auais A, Rodriguez MM, Piedimonte G (2002) Nerve growth factor and nerve growth factor receptors in respiratory syncytial virus-infected lungs. Am J Physiol Lung Cell Mol Physiol 283: L494-502.
10. Tortorolo L, Langer A, Polidori G, Vento G, Stampachiacchere B, et al. (2005) Neurotrophin overexpression in lower airways of infants with respiratory syncytial virus infection. Am J Respir Crit Care Med 172: 233-237.
11. Huang EJ, Reichardt LF (2001) Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci 24: 677-736.
12. Levi-Montalcini R (1987) The nerve growth factor 35 years later. Science 237: 1154-1162.
13. Folkerts G, Busse WW, Nijkamp FP, Sorkness R, Gern JE (1998) Virus-induced airway hyperresponsiveness and asthma. Am J Respir Crit Care Med 157: 1708-1720.
14. Fiedler MA, Wernke-Dollries K, Stark JM (1996) Mechanism of RSV-induced IL-8 gene expression in A549 cells before viral replication. Am J Physiol 271: L963-971.
15. Noah TL, Becker S (1993) Respiratory syncytial virus-induced cytokine production by a human bronchial epithelial cell line. Am J Physiol 265: L472-478.
16. Patel JA, Kunimoto M, Sim TC, Garofalo R, Eliott T, et al. (1995) Interleukin-1 alpha mediates the enhanced expression of intercellular adhesion molecule-1 in pulmonary epithelial cells infected with respiratory syncytial virus. Am J Respir Cell Mol Biol 13: 602-609.
17. McNamara PS, Ritson P, Selby A, Hart CA, Smyth RL (2003) Bronchoalveolar lavage cellularity in infants with severe respiratory syncytial virus bronchiolitis. Arch Dis Child 88: 922-926.
18. Haeberle HA, Durrstein C, Rosenberger P, Hosakote YM, Kuhlicke J, et al. (2008) Oxygen-independent stabilization of hypoxia inducible factor (HIF)-1 during RSV infection. PLoS ONE 3: e3352.
19. Sioud M (2005) Induction of inflammatory cytokines and interferon responses by double-stranded and single-stranded siRNAs is sequence-dependent and requires endosomal localization. J Mol Biol 348: 1079-1090.
20. Ott L (1977) An Introduction to statistical methods and data analysis. North Scituate, MA: Duxbury Press.
21. Zar JH (1984) Biostatistical Analysis. Englewood Cliffs, NJ: Prentice-Hall, Inc.
22. Wallenstein S, Zucker CL, Fleiss JL (1980) Some statistical methods useful in circulation research. Circ Res 47: 1-9.
23. Hall CB (2001) Respiratory syncytial virus and parainfluenza virus. N Engl J Med 344: 1917-1928.
24. Hashem M, Hall CB (2003) Respiratory syncytial virus in healthy adults: the cost of a cold. J Clin Virol 27: 14-21.
25. Johnson JE, Gonzales RA, Olson SJ, Wright PF, Graham BS (2007) The histopathology of fatal untreated human respiratory syncytial virus infection. Mod Pathol 20: 108-119.
26. Welliver TP, Garofalo RP, Hosakote Y, Hintz KH, Avendano L, et al. (2007) Severe human lower respiratory tract illness caused by respiratory syncytial virus and influenza virus is characterized by the absence of pulmonary cytotoxic lymphocyte responses. J Infect Dis 195: 1126-1136.
27. Hall CB, Long CE, Schnabel KC (2001) Respiratory syncytial virus infections in previously healthy working adults. Clin Infect Dis 33: 792-796.
28. Piedimonte G (2002) Neuroimmune interactions in respiratory syncytial virus-infected airways. Pediatr Infect Dis J 21: 462-467.
29. Kawamoto K, Okada T, Kannan Y, Ushio H, Matsumoto M, et al. (1995) Nerve growth factor prevents apoptosis of rat peritoneal mast cells through the trk proto-oncogene receptor. Blood 86: 4638-4644.
30. Hohn A, Leibrock J, Bailey K, Barde YA (1990) Identification and characterization of a novel member of the nerve growth factor/ brain-derived neurotrophic factor family. Nature 344: 339-341.
31. Freund-Michel V, Frossard N (2008) The nerve growth factor and its receptors in airway inflammatory diseases. Pharmacol Ther 117: 52-76.
32. Simoes EA (1999) Respiratory syncytial virus infection. Lancet 354: 847-852.
33. Coppola V, Barrick CA, Southon EA, Celeste A, Wang K, et al. (2004) Ablation of TrkA function in the immune system causes B cell abnormalities. Development 131: 5185-5195.
34. Mellow TE, Murphy PC, Carson JL, Noah TL, Zhang L, et al. (2004) The effect of respiratory synctial virus on chemokine release by differentiated airway epithelium. Exp Lung Res 30: 43-57.
35. Aloe L, Levi-Montalcini R (1977) Mast cells increase in tissues of neonatal rats injected with the nerve growth factor. Brain Res 133: 358-366.
36. Piedimonte G (2001) Neural mechanisms of respiratory syncytial virus-induced inflammation and prevention of respiratory syncytial virus sequelae. Am J Respir Crit Care Med 163: S18-21.
37. la Sala A, Corinti S, Federici M, Saragovi HU, Girolomoni G (2000) Ligand activation of nerve growth factor receptor TrkA protects monocytes from apoptosis. J Leukoc Biol 68: 104-110.
38. Garaci E, Caroleo MC, Aloe L, Aquaro S, Piacentini M, et al. (1999) Nerve growth factor is an autocrine factor essential for the survival of macrophages infected with HIV. Proc Natl Acad Sci U S A 96: 14013-14018.
39. Bredesen DE, Ye X, Tasinato A, Sperandio S, Wang JJ, et al. (1998) p75NTR and the concept of cellular dependence: seeing how the other half die. Cell Death Differ 5: 365-371.
40. Soilu-Hanninen M, Ekert P, Bucci T, Syroid D, Bartlett PF, et al. (1999) Nerve growth factor signaling through p75 induces apoptosis in Schwann cells via a Bcl-2-independent pathway. J Neurosci 19: 4828-4838.
41. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME (1995) Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270: 1326-1331.
42. Antoni BA, Sabbatini P, Rabson AB, White E (1995) Inhibition of apoptosis in human immunodeficiency virus-infected cells enhances virus production and facilitates persistent infection. J Virol 69: 2384-2392.
43. Groskreutz DJ, Monick MM, Babor EC, Nyunoya T, Varga SM, et al. (2009) Cigarette smoke alters respiratory syncytial virus-induced apoptosis and replication. Am J Respir Cell Mol Biol Epub ahead of print.